Stereotactic Body Radiotherapy Shows Potential in Oligometastatic Cancer

Kendra Harris, MD, MSc
Published: Friday, Mar 01, 2019
UVAKendra Harris, MD, MSc
Kendra Harris, MD, MSc
 
Interim Chair

Department of Radiation Oncology

Tulane University School of Medicine

Strategic Partnership
An increasing amount of evidence shows that a proportion of patients with cancer found to have low-volume metastases at diagnosis see meaningful benefit from aggressive local therapy. Equally important, there have been no meaningful reductions in reported quality of life among patients receiving intensive local therapy, and a small percentage of patients appear to be cured with this strategy.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Advances in™ Therapies for Patients With ALK-Positive Lung Cancers: More Options…More Decisions…Better OutcomesAug 30, 20191.5
Oncology Briefings™: Treating Advanced NSCLC Without Actionable MutationsAug 30, 20191.0
Publication Bottom Border
Border Publication
x